OncoCellMDx is a company dedicated to the development and commercialization of novel diagnostic tests using proprietary technologies. In particular, it utilizes noninvasive blood-based immunogenomic assays that help physicians to better understand the underlying pathology. Its product helps to assess the severity of prostate cancer.
|HQ||Corvallis, OR, US||Map|
OncoCell MDx total Funding
OncoCell MDx latest funding size
Time since last funding
|2 years ago|
OncoCell MDx investors
OncoCell MDx has 65 Twitter Followers. The number of followers has increased 3.5% month over month and increased 5.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was OncoCell MDx founded?
OncoCell MDx was founded in 2011.
Who are OncoCell MDx key executives?
OncoCell MDx's key executives are Mark McDonough, Harry Stylli and Amin Kassis.
Who are OncoCell MDx competitors?
Competitors of OncoCell MDx include Cepheid, RiboMed Biotechnologies and SageMedic.
Where is OncoCell MDx headquarters?
OncoCell MDx headquarters is located at 582 NW Van Buren Ave, Corvallis.
Where are OncoCell MDx offices?
OncoCell MDx has offices in Corvallis and Royal Oak.
How many offices does OncoCell MDx have?
OncoCell MDx has 2 offices.
Receive alerts for 300+ data fields across thousands of companies